$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Comparison of the efficacy and safety of capmatinib (Touradida) and tepotinib
2026-02-01 22:25:32
Check Details
How long does it take to develop resistance to Sotoraxib (AMG 510) and how to delay resistance
2026-02-01 22:25:32
Check Details
Adverse reaction management strategies for adagrasib (Krazati) and medication guidance for high-risk patients
2026-02-01 22:25:32
Check Details
Actual therapeutic effect and clinical efficacy evaluation of Pimitespib
2026-02-01 22:25:32
Check Details
Afatinib (Gitarel) indication scope and evaluation of therapeutic effect
2026-02-01 22:25:32
Check Details
What type of psychotropic drugs does DaliRasheng (Keweike) belong to and its safety analysis
2026-02-01 22:25:32
Check Details
The best plan and precautions for taking Lynparza before and after meals
2026-02-01 22:25:32
Check Details
Analysis of how long to take Venetoclax/Venetoclax (Vekela) to see obvious effects
2026-02-01 22:25:32
Check Details
Analysis of the functions, efficacy and scope of application of Asnib/Asiminib
2026-02-01 22:25:32
Check Details
Analysis on whether it is necessary to adhere to the medication for a long time after taking ritexitinib (Lefenox)
2026-02-01 22:25:32
Check Details
Clinical effects and patient evaluations of sparsentan (sparsentan) in the treatment of kidney disease
2026-02-01 22:25:32
Check Details
How many years can long-term maintenance treatment with Ixazomib (Enleri) be maintained and its efficacy evaluated?
2026-02-01 22:25:32
Check Details
1
2
...
2141
2142
2143
2144
2145
2146
2147
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
2
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
3
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
4
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
5
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
6
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
7
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
8
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
9
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
10
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
11
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
12
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection